ApoE4 can also affect the cerebrovascular system by accumulation of neurotoxins such as β-amyloid (Aβ) [6] and activate expression of GFAP and other 5 oxidized proteins which were already discovered in AD patients' brains [7, 8]. Here, GFAP is linked to Alzheimer disease.